Guangxi LiuYao Group Co., Ltd (SHA:603368)
16.63
-0.12 (-0.72%)
Mar 26, 2026, 3:00 PM CST
Guangxi LiuYao Group Market Cap
Guangxi LiuYao Group has a market cap or net worth of 6.52 billion as of March 25, 2026. Its market cap has decreased by -5.88% in one year.
Market Cap
6.52B
Enterprise Value
8.78B
Revenue
20.95B
Ranking
n/a
PE Ratio
8.47
Stock Price
16.63
Market Cap Chart
Since December 4, 2014, Guangxi LiuYao Group's market cap has increased from 4.25B to 6.52B, an increase of 53.42%. That is a compound annual growth rate of 3.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 6.52B | -5.99% |
| Dec 31, 2025 | 6.93B | -2.61% |
| Dec 31, 2024 | 7.12B | 4.58% |
| Dec 29, 2023 | 6.81B | 0.66% |
| Dec 30, 2022 | 6.76B | -1.81% |
| Dec 31, 2021 | 6.89B | -11.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Pharmaceuticals Holding | 54.41B |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company | 35.87B |
| Jointown Pharmaceutical Group | 24.73B |
| China National Medicines Corporation | 21.17B |
| Liaoning Cheng Da | 16.55B |
| China Meheco Group | 14.64B |
| China National Accord Medicines Corporation | 12.70B |
| Qingdao Baheal Medical INC. | 10.61B |